Gene · 23569
Papers4,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blocking peptidyl arginine deiminase 4 confers neuroprotective effect in the post-ischemic brain through both NETosis-dependent and -independent mechanisms. | Acta Neuropathol Commun | 2025 | 39966968 | PubTator, text mining | PubMed |
| An Integrated Network Pharmacology and RNA-seq Approach for Exploring the Protective Effect of Isoquercitrin in Doxorubicin-Induced Cardiotoxicity: Identification of Novel Genes. | Cardiovasc Toxicol | 2025 | 39964600 | PubTator, text mining | PubMed |
| Padi4-Dependent NETosis Enables Diet-Induced Gut Hyperpermeability, Translating Dysbiosis Into Systemic Inflammation and Dysmetabolism. | Diabetes | 2025 | 39945856 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps-induced pyroptosis of liver sinusoidal endothelial cells exacerbates intrahepatic coagulation in cholestatic mice. | Biochim Biophys Acta Mol Basis Dis | 2025 | 39914029 | PubTator, text mining | PubMed |
| Platelet-derived HMGB1 induces NETosis, exacerbating brain damage in the photothrombotic stroke model. | Mol Med | 2025 | 39910417 | PubTator, text mining | PubMed |
| Circulating levels of PADs and citrullinated histone H3 in SARS-CoV-2 infection: Influence of genetic polymorphisms. | Clin Chim Acta | 2025 | 39904454 | PubTator, text mining | PubMed |
| 5-HT orchestrates histone serotonylation and citrullination to drive neutrophil extracellular traps and liver metastasis. | J Clin Invest | 2025 | 39903533 | PubTator, text mining | PubMed |
Constraint-induced movement therapy combined with intermittent theta-burst stimulation improve synaptic plasticity by inhibiting neutrophils extracellular traps formation in ipsilateral primary motor cortex of stroke rats. | Neurosci Lett | 2025 | 39880071 | PubTator, text mining | PubMed |
| Intestinal neutrophil extracellular traps promote gut barrier damage exacerbating endotoxaemia, systemic inflammation and progression of diabetic retinopathy in type 2 diabetes. | Diabetologia | 2025 | 39875729 | PubTator, text mining | PubMed |
The methyl-CpG binding domain 2 regulates peptidylarginine deiminase 4 expression and promotes neutrophil extracellular trap formation via the Janus kinase 2 signaling pathway in experimental severe asthma. | Ann Med | 2025 | 39865866 | PubTator, text mining | PubMed |
| Citrullination at the N-terminal region of MDM2 by the PADI4 enzyme. | Protein Sci | 2025 | 39840810 | PubTator, text mining | PubMed |
| NFE2-driven neutrophil polarization promotes pancreatic cancer liver metastasis progression. | Cell Rep | 2025 | 39827463 | PubTator, text mining | PubMed |
| The role of Anti-PAD4, Anti-CarP, and Anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis. | Arthritis Res Ther | 2025 | 39815378 | PubTator, text mining | PubMed |
| Inhibition of NETs prevents doxorubicin-induced cardiotoxicity by attenuating IL-18-IFN-γ-Cx43 axis induced cardiac conduction abnormalities. | Int Immunopharmacol | 2025 | 39805175 | PubTator, text mining | PubMed |
| Glycyrrhizic acid reduces neutrophil extracellular trap formation to ameliorate colitis-associated colorectal cancer by inhibiting peptidylarginine deiminase 4. | J Ethnopharmacol | 2025 | 39788166 | PubTator, text mining | PubMed |
| Sepsis-induced NET formation requires MYD88 but is independent of GSDMD and PAD4. | FASEB J | 2025 | 39777764 | PubTator, text mining | PubMed |
| Inhibition of peptidyl arginine deiminase-4 ameliorated pulmonary fibrosis via modulating M1/M2 polarisation of macrophages. | Life Sci | 2025 | 39755270 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps formation and autophagy in bongkrekic acid exposed human neutrophils. | Toxicol In Vitro | 2025 | 39730015 | PubTator, text mining | PubMed |
| Insights into the complexities of Citrullination: From immune regulation to autoimmune disease. | Autoimmun Rev | 2025 | 39719187 | PubTator, text mining | PubMed |
| Silencing PADI-2 induces antitumor effects by downregulating NF-κB, Nrf2/HO-1 and AKT1 in A549 lung cancer cells. | Int Immunopharmacol | 2025 | 39700962 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23569/papers?page=19